A2 vs Regular Milk for Lactose Intolerance
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if milk containing only A2 beta-casein causes fewer symptoms and less inflammation in individuals with lactose intolerance. Participants will consume either regular milk, which contains both A1 and A2 proteins, or A2 milk, which contains only A2 protein, for two weeks. The study will assess any differences in how these milk types affect inflammation and symptoms such as gas and bloating. Individuals who avoid dairy due to discomfort, like gas or cramps, might be well-suited for this trial. As an unphased study, this trial provides a unique opportunity to explore potential dietary solutions for those experiencing discomfort from dairy.
Will I have to stop taking my current medications?
The trial requires participants to stop using treatments and products for dairy intolerance, like Lactaid® Dietary Supplements, during the study. If you are using any other medications, the protocol does not specify, so it's best to discuss with the study staff.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that milk containing only A2 protein is usually easier to digest. Studies have found that people who drink A2 milk experience fewer symptoms of lactose intolerance compared to those who consume milk with both A1 and A2 proteins. This suggests that A2 milk might be gentler on the stomach. Evidence also indicates that A1 milk can cause more inflammation, which A2 milk does not.
For those seeking to avoid stomach issues, A2 milk could be a better choice. However, A2 milk is not safe for individuals with a milk allergy. It's always important to understand what works best for one's own body.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for lactose intolerance because they explore the potential benefits of A2 beta-casein, a protein found in milk. Unlike regular milk, which contains both A1 and A2 beta-casein, A2 milk is thought to be easier on the digestive system for those who are lactose intolerant. This is because some research suggests that A1 beta-casein may cause digestive discomfort, while A2 beta-casein does not. These treatments could offer a more comfortable alternative to lactose-free milk options, providing a similar taste and nutritional profile without the digestive issues.
What evidence suggests that this trial's treatments could be effective for lactose intolerance?
This trial will compare the effects of milk containing only A2 beta-casein with milk containing both A1 and A2 beta-casein on symptoms of lactose intolerance. Research has shown that milk with only A2 protein causes fewer symptoms of lactose intolerance than milk with both A1 and A2 proteins. Specifically, studies have found that A2 milk leads to less stomach pain, urgent bowel movements, and stomach rumbling. In contrast, milk with A1 protein is linked to more gut inflammation and slower digestion. Several studies confirm that switching to A2 milk can significantly reduce symptoms like bloating and digestive discomfort. Overall, the evidence suggests that A2 milk may be a better choice for those sensitive to regular milk.678910
Who Is on the Research Team?
Dennis Savaiano, PhD
Principal Investigator
Purdue University
Are You a Good Fit for This Trial?
Adults aged 18-65 with a history of lactose intolerance who have avoided dairy for at least a month can join. They must be willing to attend all study visits, avoid other dairy intolerance treatments during the trial, and not have conditions like severe ulcers, diabetes, milk allergies, heart failure or recent drug/alcohol abuse.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention Phase 1
Participants consume the first randomized milk for 14 days and undergo hydrogen breath test on day 15
Intervention Phase 2
Participants consume the second randomized milk for 14 days and undergo hydrogen breath test on day 15
Follow-up
Participants are monitored for any delayed symptoms or reactions after the intervention phases
What Are the Treatments Tested in This Trial?
Interventions
- Milk containing A1 and A2 beta-casein
- Milk containing only A2 beta-casein
Milk containing A1 and A2 beta-casein is already approved in European Union, United States, Canada for the following indications:
- General nutrition
- Dietary supplement
- General nutrition
- Dietary supplement
- General nutrition
- Dietary supplement
Find a Clinic Near You
Who Is Running the Clinical Trial?
Purdue University
Lead Sponsor